This study included 83 MS patients that where treated with either Interferon or Copaxone. Due to worsening 21 of them switched to a combined therapy for 16-24 months.
Apart from high perceived psychological impact in the combination group, no other significant differences between treatments were found.
--Frank
Combination therapy of Interferon+Copaxone
Combination therapy of Interferon+Copaxone
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.